Delivery Order SPE2DB20D3304-SPE2DB25FW8M5
- Not listed
- The Defense Logistics Agency awarded a $2,015.65 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, on August 8, 2025, with completion expected by August 11, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger relationship with the federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,545.30 for Trulicity 1.5 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction under AmerisourceBergen's broader federal contract portfolio. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,351.35 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on August 1, 2025, with completion targeted for August 4, 2025. This firm fixed price, competitively awarded contract involves the supply of the diabetes medication from AmerisourceBergen's Conshohocken, Pennsylvania facility. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the Defense...
- The Defense Logistics Agency awarded a $1,383.93 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 1, 2025, with completion expected by August 4, 2025. This firm fixed-price contract, issued without set-aside designation, leverages AmerisourceBergen's established relationship with DLA through competitive procurement procedures. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $2,036.86 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract, awarded on July 30, 2025, carries a firm fixed price structure with an ultimate completion date of July 31, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,500.88 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price delivery order is a non-set-aside contract with an ultimate completion date of July 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,702.69 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025, under a firm fixed-price contract type. This represents a non-set-aside competitive award, with performance to be conducted at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,478.24 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This firm fixed-price, non-set-aside contract was awarded on July 30, 2025, with a completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $3,876.35 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen pharmaceutical supplies on August 1, 2025, with completion scheduled for August 4, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery will be performed at AmerisourceBergen's corporate...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW8M5Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,663.27 for Trulicity 1.5 mg/0.5 ml pen 0.5ml, a diabetes medication, with an ultimate completion date of August 13, 2025. This non-competitive, firm fixed-price delivery order was awarded on August 12, 2025, with performance to be executed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's federal contracting demonstrates its established capability as a critical pharmaceutical distributor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/12/25 |